Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
222.20    -0.40 (-0.18%)
Bid:
222.00
Ask:
222.60
Spread: 0.60 (0.27%)
Market Cap: £2.27b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Pricing of Senior Notes

10 Jun 2020 07:00

RNS Number : 4602P
Helios Towers PLC
10 June 2020
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933 (THE "U.S. SECURITIES ACT")) OR IN OR INTO ANY OTHER JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

 

 

HELIOS TOWERS ANNOUNCES PRICING OF U.S.$750 MILLION AGGREGATE PRINCIPAL AMOUNT OF 7.00% SENIOR NOTES DUE 2025

 

June 10, 2020 - HTA Group, Ltd. (the "HTA Group"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the successful pricing of its offering of 7.00% senior notes due 2025 (the "Notes"), guaranteed on a senior basis by the Company and certain of its direct and indirect subsidiaries (the "Offering").

 

Offering of Senior Notes

 

The Notes will be issued at an issue price of 99.439% of principal amount. HTA Group will pay interest on the Notes semi-annually in arrears on each June 18 and December 18, commencing on December 18, 2020.

 

The proceeds of the Notes will be used (i) to redeem all of HTA Group's outstanding senior notes due 2022 (the "Existing Notes") (plus accrued interest), (ii) to repay all amounts outstanding under its U.S.$125 million term facility (of which, as of the date hereof, approximately U.S.$75 million was outstanding), (iii) to pay certain fees and expenses in relation to the Offering and (iv) with excess funds available for general corporate purposes.

 

New Term and Revolving Credit Facilities

 

As previously announced, HTA Group has entered into a U.S.$135 million term facility (with a 5-year tenor, and which may increase in accordance with its terms up to an aggregate amount of U.S.$200 million) with borrowing availability in U.S. dollars for the general corporate purposes (including acquisitions) of the Company and certain of its subsidiaries. This new term facility will replace the existing U.S.$125 million term facility, which will be cancelled upon completion of the Offering.

 

Additionally, HTA Group entered into a revolving credit facility (with a 4.5-year tenor) with borrowing availability in U.S. dollars for the purpose of financing or refinancing the general corporate and working capital needs of the Company and certain of its subsidiaries. Commitments under the new revolving credit facility amount to U.S.$70 million and will replace the existing U.S.$60 million revolving credit facility, which will be cancelled upon completion of the Offering.

 

Drawings under the new facilities are conditioned upon the closing of the Offering.

 

Tom Greenwood, Chief Financial Officer, said:

 

"We are incredibly pleased to announce the successful pricing of our bond offering today. Given that we are reopening the African corporate debt capital markets after the COVID-19 volatility, we initially envisaged a smaller new issuance of $425m with a tender offer for up to $325m of our outstanding existing 2022 Senior Notes. However demand and pricing for the new Senior Notes offering was such that we upsized to a $750m issuance and the full redemption of the existing 2022 Senior Notes.

 

This success was achieved as a result of having further demonstrated a track record of successful growth in long-term contracted revenues and resilient cashflows. As a consequence we have not only been able to upsize the offering and significantly reduce our cost of borrowing, but also raise a new term loan in order to invest into the expansionary opportunities on the continent.

 

We thank our bond and term loan investors for their continued support and look forward to partnering with them as we continue with our exciting growth plans."

 

 

* * * * *

 

This announcement is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the Notes or the Existing Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such offer, solicitation or sale would be unlawful. The Notes and the guarantees in respect thereof have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction. Securities may not be offered in the United States absent registration or an exemption from registration. Accordingly, the Notes are being offered and sold only to "qualified institutional buyers" as defined in and in reliance on Rule 144A under the Securities Act and outside the United States to non-U.S. persons as defined in, and in accordance with, Regulation S under the Securities Act. No action has been or will be taken in any jurisdiction in relation to the Notes to permit a public offering of securities. There is no assurance that any Notes offering will be completed or, if completed, as to the terms on which it is completed.

 

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA") or the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II") or (ii) a customer within the meaning of Directive 2016/97/EU (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the EEA or the United Kingdom has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA or the United Kingdom may be unlawful under the PRIIPS Regulation.

 

FCA/ICMA Stabilisation

 

MiFID II professionals/ECPs-only - Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA or the United Kingdom.

 

This announcement is being distributed to, and is directed at, only persons who (i) are outside the United Kingdom; (ii) have professional experience in matters relating to investments and who qualify as investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ''Financial Promotion Order''), (iii) fall within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order; or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000, as amended (the ''FSMA'') in connection with the issue or sale of any Notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as ''relevant persons''). The investments to which this announcement relates are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such investments will be available only to or will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents. Persons distributing this announcement must satisfy themselves that it is lawful to do so.

 

The distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such jurisdiction.

 

Forward-Looking Information

 

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Company concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Company and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

 

 

Investor contact:

Helios Towers plc

Manjit Dhillon, Investor Relations

+44 7767 237 010

Media contact:

FTI Consulting LLP

Edward Bridges/Stephanie Ellis

+44 203 727 1017

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLMMTMTMMTTM
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20263:41 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20263:26 pmRNSTotal Voting Rights
28th May 202610:15 amRNSHolding(s) in Company
26th May 20267:00 amRNSTransaction in Own Shares
20th May 202612:13 pmRNSHolding(s) in Company
20th May 20267:00 amRNSHolding(s) in Company
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20261:10 pmRNSDirector/PDMR Shareholding
14th May 20261:12 pmRNS2026 Annual General Meeting Results
11th May 20267:37 amRNSTransaction in Own Shares
8th May 20267:11 amRNSHolding(s) in Company
7th May 20267:00 amRNSQ1 2026 Results
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20268:47 amRNSHolding(s) in Company
30th Apr 20264:03 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202612:20 pmRNSHolding(s) in Company
8th Apr 202610:49 amRNSNotice of Q1 2026 Results Date & Conference Call
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:34 pmRNSTotal Voting Rights
30th Mar 20269:50 amRNSAnnual Report and Notice of AGM
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202612:00 pmRNSDirector/PDMR Shareholding
25th Mar 20266:08 pmRNSHelios Towers announces pricing of Senior Notes
24th Mar 202611:43 amRNSLAUNCH OF OFFER OF SENIOR NOTES
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20263:14 pmRNSDirector/PDMR Shareholding
16th Mar 20263:14 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFull Year Results 2025
12th Mar 20267:00 amRNSFull Year Results 2025
9th Mar 20264:15 pmRNSDirectorate change
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20264:19 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.